Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Respiratory Viral Infection: later-stage trial registry
2 of 5 indexed Respiratory Viral Infection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Respiratory Viral Infection: 5 US clinical trials tracked, 2 recruiting.
Respiratory Viral Infection is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Evidation Health, running 1 of these trials.
Enrollment posture brief
Registry condition respiratory-viral-infection
OPEN 2 | RECR 40% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Respiratory Viral Infection lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Respiratory Viral Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Respiratory Viral Infection is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Respiratory Viral Infection research.
Evidation Health accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Respiratory Viral Infection enrolment sits around 1,400 participants.
Median target enrolment is 1,400 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Respiratory Viral Infection splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Arkansas Children's Hospital Research Institute
NCT05550298
Dime La VerDAD: Verify, Debunk, and Disseminate
University of Chicago
NCT06417762
Wells and Enteric Disease Transmission
Temple University
NCT04826991
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
Medical University of South Carolina
NCT04482673
Home Testing of Respiratory Illness
Evidation Health
NCT04245800
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Respiratory Viral Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Respiratory Viral Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Respiratory Viral Infection page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Respiratory Viral Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Evidation Health sponsors the most Respiratory Viral Infection trials on record, review their full trial history before evaluating a specific study. See Evidation Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Respiratory Viral Infection condition card totals 5 registered trials; most-linked intervention Bolus placebo; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.